Mediwound to host third quarter 2014 financial results conference call
on november 5, 2014 at 4:30 p.m. eastern time
Yavne, israel--(business wire)--mediwound ltd. (nasdaq:mdwd), a fully-integrated, biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that the company will release financial results for the three and nine months ended september 30, 2014, after the market close on wednesday, november 5, 2014. following the release, mediwound's management will host a conference call for the investment community beginning at 4:30 p.m. et on wednesday, november 5, 2014, to discuss the financial results and to answer questions. shareholders and other interested parties may participate in the conference call by dialing (877) 602-7189 (domestic) or (678) 894-3057 (international) and entering passcode 26917687. the call also will be broadcast live on the internet at www.streetevents.com and www.mediwound.com. a replay of the call will be accessible two hours after its completion through november 11, 2014 by dialing (855) 859-2056 (domestic) or (404) 537-3406 (international) and entering passcode 26917687. the call will also be archived for 90 days at www.streetevents.com and www.mediwound.com. about mediwound ltd. mediwound is a fully integrated biopharmaceutical company focused on developing, manufacturing and commercializing novel therapeutics based on its patented proteolytic enzyme technology to address unmet needs in the fields of severe burns, chronic and other hard-to-heal wounds. mediwound’s first innovative biopharmaceutical product, nexobrid, received marketing authorization from the european medicines agency for removal of dead or damaged tissue, known as eschar, in adults with deep partial and full-thickness thermal burns and was launched in europe. nexobrid represents a new paradigm in burn care management, and clinical trials have demonstrated, with statistical significance, its ability to non-surgically and rapidly remove the eschar earlier and, without harming viable tissues. for more information, please visit www.mediwound.com.
MDWD Ratings Summary
MDWD Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission